04/30/2024
3:46 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/30/2024
3:35 PM | Vaxxinity (Filer)
| Form S-8 POS | |
04/29/2024
4:06 PM | Vaxxinity (Filer)
| Form 10-K/A | |
04/29/2024
3:46 PM | Vaxxinity (Filer)
| Form PRE 14C | |
03/27/2024
3:18 PM | Vaxxinity (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
3:15 PM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
3:04 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
12/01/2023
9:30 AM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
4:03 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
4:13 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
4:10 PM | Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
3:20 PM | Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
3:21 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
6:53 AM | Vaxxinity (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/03/2023
3:31 PM | Paula Molina Rene (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
8:42 PM | Powchik Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
8:40 PM | Ray Sumita (Reporting)
Vaxxinity (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
3:33 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/28/2023
3:15 PM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
3:12 PM | Prime Movers Growth GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:16 PM | Prime Movers Lab GP I LLC (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:10 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:11 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:14 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:18 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/14/2023
4:19 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:34 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:24 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:26 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:31 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:18 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:32 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:00 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:01 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023
4:02 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
4:02 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
4:12 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
4:20 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:52 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023
3:42 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
5:05 PM | Prime Movers Lab Fund I LP (Reporting)
Sloss Dakin (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Gold Mania (Ad) Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential
He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. |
09/08/2023
4:33 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
4:14 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
4:23 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/08/2023
3:50 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:38 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:42 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:26 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:32 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:20 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:13 PM | COVAXX PML SPV 2 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:14 PM | Covaxx PML SPV 3 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:15 PM | Covaxx PML SPV 1 LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:16 PM | Prime Movers Growth Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2023
3:18 PM | Prime Movers Lab Fund I LP (Reporting)
Vaxxinity (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2023
11:15 PM | Vaxxinity (Filer)
| Form EFFECT | |
08/09/2023
6:30 AM | Vaxxinity (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
6:31 AM | Vaxxinity (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/26/2023
5:31 PM | Powchik Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:32 PM | Diamandis Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:34 PM | TOLEDANO GABRIELLE B (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:35 PM | Eade Katherine A. (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:37 PM | Ogilvie Landon E (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:37 PM | Smith James Alan (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:39 PM | HORNIG GEORGE R (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:30 PM | Vaxxinity (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
6:00 AM | Vaxxinity (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
4:26 PM | Vaxxinity (Filer)
| Form S-8 POS | |
05/02/2023
9:46 AM | Diamandis Peter (Reporting)
Vaxxinity (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
